TRIPTOLIDE IS A POTENTIAL THERAPEUTIC AGENT FOR ALZHEIMER’S DISEASE
Mounting evidence indicates an involvement of inflammation in the pathogenesis of Alzheimer’s disease. While there are other mechanisms involved, it is this role of inflammatory processes that we wish to investigate. Triptolide is the major constituent in the Chinese herb, Tripterygium wilfordii...
Main Author: | Allsbrook, Matthew |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2009
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/1858 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=2857&context=etd |
Similar Items
-
Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection
by: Hui-Fang Zhou, et al.
Published: (2005-04-01) -
Effects of triptolide on hippocampal microglial cells and astrocytes in the APP/PS1 double transgenic mouse model of Alzheimer′s disease
by: Jian-ming Li, et al.
Published: (2016-01-01) -
Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
by: Qi Wang, et al.
Published: (2014-12-01) -
Microglia in Alzheimer’s Disease: Activated, Dysfunctional or Degenerative
by: Victoria Navarro, et al.
Published: (2018-05-01) -
Identification of a binding target of triptolide and related studies
by: Zhao, Qian, et al.
Published: (2013)